40 CFR §721.9700
Verified against eCFR.gov as of June 20, 2026View official text on eCFR.gov ↗
- (a)Chemical substances and significant new uses subject to reporting.
- (1)The chemical substance monosubstituted alkoxyaminotrazines (PMN P-86-1043) is subject to reporting under this section for the significant new uses described in paragraph (a)(1)(i) of this section.
- (i)The significant new uses are:
- (A)Protection in the workplace. Requirements as specified in § 721.63 (a)(1) and (a)(3), (b) [concentration set at 0.1 percent], and (c).
- (B)Hazard communication program. Requirements as specified in § 721.72 (b)(2), (d), (e) [concentration set at 0.1 percent], (f), and (g)(1)(iv), (g)(1)(vii), and (g)(1)(viii), (g)(2)(i) and (g)(2)(v), (g)(4)(xi), and (g)(5). The provisions of § 721.72(d) requiring employees to be provided with information on the location and availability of a written hazard communication program and SDSs do not apply when the written program and SDS are not required under § 721.72 (a) and (c), respectively. The provision of § 721.72(g) requiring placement of specific information on a SDS does not apply when a SDS is not required under § 721.72(c).
- (C)Industrial, commercial, and consumer activities. Requirements as specified in § 721.80(k).
- (D)Disposal. Requirements as specified in § 721.85 (a)(1) and (a)(2) and (b)(1) and (b)(2).
- (E)Release to water. Requirements as specified in § 721.90 (a)(4) [concern level of 10 ppb], (b)(4) [concern level of 10 ppb], and (c)(4) [concern level of 10 ppb].
- (ii)[Reserved]
- (i)The significant new uses are:
- (2)The chemical substance monosubstituted alkoxyaminotrazines (PMN P-86-1044) is subject to reporting under this section for the significant new uses described in paragraph (a)(2)(i) of this section.
- (i)The significant new uses are:
- (A)Protection in the workplace. Requirements as specified in § 721.63 (a)(1), (a)(3), (a)(4), (a)(5)(iii) through (a)(5)(vii), and (a)(6)(i), (b) [concentration set at 0.1 percent], and (c).
- (B)Hazard communication program. Requirements as specified in § 721.72 (b)(2), (d), (e) [concentration set at 0.1 percent], (f), and (g)(1)(iv), (g)(1)(vii), and (g)(1)(viii), (g)(2)(i), (g)(2)(ii), (g)(2)(iv), and (g)(2)(v), (g)(4)(xi), and (5). The provisions of § 721.72(d) requiring employees to be provided with information on the location and availability of a written hazard communication program and SDSs do not apply when the written program and SDS are not required under § 721.72 (a) and (c), respectively. The provision of § 721.72(g) requiring placement of specific information on a SDS does not apply when a SDS in not required under § 721.72(c).
- (C)Industrial, commercial, and consumer activities. Requirements as specified in § 721.80(k).
- (D)Disposal. Requirements as specified in § 721.85 (a)(1) and (a)(2) and (b)(1) and (b)(2).
- (E)Release to water. Requirements as specified in § 721.90 (a)(4) [concern level of 1 ppb], (b)(4) [concern level of 1 ppb], and (c)(4) [concern level of 1 ppb].
- (ii)[Reserved]
- (i)The significant new uses are:
- (1)The chemical substance monosubstituted alkoxyaminotrazines (PMN P-86-1043) is subject to reporting under this section for the significant new uses described in paragraph (a)(1)(i) of this section.
- (b)Specific requirements. The provisions of subpart A of this part apply to this section except as modified by this paragraph.
- (1)Recordkeeping. The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a) through (k).
- (2)Limitations or revocation of certain notification requirements. The provisions of § 721.185 apply to this significant new use rule.
- (3)Determining whether a specific use is subject to this section. The provisions of § 721.1725(b)(1) apply to this section.